Furthermore, efflux pumps (ABCB1, MRP1) and influx transporters (SLC7A11) significantly impact drug bioavailability, while age-dependent CYP metabolism and tumor-specific isoforms such as CYP2W1 represent metabolic vulnerabilities. The gene discussed is SLC7A11; the disease is neoplasm.